Literature DB >> 29028174

Could Frequent Carbapenem Use Be a Risk Factor for Colistin Resistance?

Aycan Gundogdu1,2, Aysegul Ulu-Kilic3,4, Huseyin Kilic1, Esra Ozhan4, Dilek Altun4, Ozlem Cakir4, Emine Alp3,4.   

Abstract

AIMS: The antibiotic colistin, which had been previously abandoned, is being brought back as a last line of defense against bacterial infection. However, colistin resistance was reported shortly after its reintroduction. This study evaluated the risk factors for colonization/infections due to colistin-resistant Acinetobacter baumannii (ColR-Ab) and Klebsiella pneumoniae (ColR-Kp) strains and characterized the molecular epidemiology of these two strains.
RESULTS: Age, previous hospitalization duration, and previous use of carbapenem and colistin were risk factors for ColR-Kp, whereas previous use of carbapenem and colistin was a risk factor for ColR-Ab. According to pulsed-field gel electrophoresis analysis, most ColR-Kp strains could be grouped into two major pulsotypes. This appears to be an indicator of cross contamination of ColR-Kp strain, since different isolates appeared to be belonging to the same clones. The existence of colistin-susceptible (ColS) and colistin-resistant (ColR) strains in the same pulsotypes might also be an indicator of the recent emergence of resistance mechanisms.
CONCLUSIONS: The results highlight the emergence of ColR pathogens in Turkey, which is considered to be developing country, and that carbapenem use coupled with insufficient infection control measures might increase the risk of ColR outbreaks.

Entities:  

Keywords:  carbapenems usage; colistin-resistant A. baumannii; colistin-resistant K. pneumoniae; developing countries; outbreak

Mesh:

Substances:

Year:  2017        PMID: 29028174     DOI: 10.1089/mdr.2016.0321

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  3 in total

1.  Quantifying the effect of in-hospital antimicrobial use on the development of colistin-resistant Acinetobacter baumannii strains: a time series analysis.

Authors:  Rania Kousovista; Christos Athanasiou; Konstantinos Liaskonis; Olga Ivopoulou; Vangelis D Karalis
Journal:  Eur J Hosp Pharm       Date:  2022-03

2.  Emergent Polymyxin Resistance: End of an Era?

Authors:  Zekun Li; Yuping Cao; Lingxian Yi; Jian-Hua Liu; Qiwen Yang
Journal:  Open Forum Infect Dis       Date:  2019-10-01       Impact factor: 3.835

Review 3.  Colistin Resistance in Enterobacterales Strains - A Current View.

Authors:  Elżbieta M Stefaniuk; Stefan Tyski
Journal:  Pol J Microbiol       Date:  2019-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.